Search results
Results from the WOW.Com Content Network
The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.It later moved its headquarters to New Jersey. In 2004, BD agreed to pay out US$100 million to settle allegations from competitor Retractable Technologies that it had engaged in anti-competitive behavior to prevent the distribution of Retractable's syringes, which are designed to prevent needlestick ...
CareFusion was created in 2009 as a spinoff of medical technology businesses from Cardinal Health. [1] It began publicly trading on the New York Stock Exchange on September 1, 2009. [2]
Becton's stock rose as high as $287.32, topping the previous intra-day record of $279.38 hit in February 2020. ... Shares of Becton Dickinson hit an all-time high on Monday and were last up 6.1% ...
The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in ... Becton Dickinson & Co: BDX: Health Care ... (SYY), and T. Rowe Price ...
The stock of Becton, Dickinson and Co (NYSE:BDX, 30-year Financials) is estimated to be fairly valued, according to GuruFocus Value calculation.
For premium support please call: 800-290-4726 more ways to reach us
Becton Dickinson (NYSE:BDX) has had a rough month with its share price down 10%. However, the company's fundamentals...
C. R. Bard, Inc. was founded in New York City by Charles R. Bard in 1907. Bard's first business involved importing Gomenol, which was used to treat urinary discomfort. [6] The company formally incorporated in 1923, and three years later, in 1926, Charles R. Bard sold the company to John F. Willits and Edson L. Outwin for $18,000.